Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Dec 7;188(11):2067-74.
doi: 10.1084/jem.188.11.2067.

Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity

Affiliations

Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity

K Imada et al. J Exp Med. .

Abstract

We have analyzed the immune system in Stat5-deficient mice. Although Stat5a-/- splenocytes have a partial defect in anti-CD3-induced proliferation that can be overcome by high dose interleukin (IL)-2, we now demonstrate that defective proliferation in Stat5b-/- splenocytes cannot be corrected by this treatment. Interestingly, this finding may be at least partially explained by diminished expression of the IL-2 receptor beta chain (IL-2Rbeta), which is a component of the receptors for both IL-2 and IL-15, although other defects may also exist. Similar to the defect in proliferation in activated splenocytes, freshly isolated splenocytes from Stat5b-/- mice exhibited greatly diminished proliferation in response to IL-2 and IL-15. This results from both a decrease in the number and responsiveness of natural killer (NK) cells. Corresponding to the diminished proliferation, basal as well as IL-2- and IL-15-mediated boosting of NK cytolytic activity was also greatly diminished. These data indicate an essential nonredundant role for Stat5b for potent NK cell-mediated proliferation and cytolytic activity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Extracts from thymuses (lanes 1–3) or spleens (lanes 4–6) were isolated from wild-type mice (lanes 1, 4), Stat5a−/− mice (lanes 2, 5), or Stat5b−/− mice (lanes 3, 6), and proteins were then separated by SDS-PAGE and Western blotted with antisera specific for Stat5a (top) or Stat5b (bottom). (B) Diminished thymocyte numbers in Stat5b−/−mice (7–10-wk-old mice were analyzed). (C and D) Flow cytometric analysis of thymocytes from 8-wk-old mice. (C) CD4 versus CD8 flow cytometric profiles. (D) CD25 versus CD44 flow cytometric profiles of double negative thymocytes. (E) Diminished numbers of splenocytes in Stat5b−/− mice (7–10-wk-old mice were analyzed). (F–H) Flow cytometric profiles (8-wk-old mice) show a decrease in the ratio of CD3+ to B220+ cells (F) and a decrease in the percentage of CD8+ single positive T cells (G) in Stat5b−/− mice. The percentage of TCR-α/β and TCR-γ/δ cells was normal in Stat5b−/− mice (H).
Figure 2
Figure 2
(A) Diminished IL-2–induced IL-2Rα expression in both CD4+ and CD8+ subpopulations of T cells after their preactivation with anti-CD3. Fresh splenocytes were stimulated in Falcon 3003 plates coated with 10 μg/ml anti-CD3ε mAb for 48 h, washed twice with PBS, and then cultured with or without 2 nM IL-2 for 48 h. Cells were stained with anti-CD25–FITC, anti-CD4–PE, and anti-CD8–Cy-Chrome. Shown are IL-2Rα expression and mean fluorescent intensity on CD4+ or CD8+ T cells from one representative mouse out of eight mice analyzed. (B) Northern blotting for IL-2Rα, IL-2Rβ, or control pHe7 using RNA from preactivated splenocytes not treated or treated with IL-2. Shown are representative data from three mice. (C) The relative levels of IL-2Rα and IL-2Rβ mRNA expression in B were normalized for pHe7 expression. (D) High dose IL-2 (1 nM) could not restore proliferation of Stat5b−/− splenocytes preactivated with anti-CD3. Shown are the mean ± SEM from a compilation of two independent experiments. (E) Proliferation to PMA plus IL-4 was done in Stat5b−/− splenocytes. Shown are the mean ± SD from a compilation of two experiments. In one experiment, we confirmed that treatment of cells with PMA alone or IL-4 alone yielded minimal proliferation even in wild type mice. (F) Equivalent expression of Stat6 in splenocytes from wild-type, Stat5a−/− and Stat5b−/− mice.
Figure 3
Figure 3
(A) Diminished proliferation of freshly isolated splenocytes from Stat5b−/− mice to 2 nM IL-2 or 7.75 nM IL-15. Shown are the mean ± SD from a compilation of two independent experiments. (B) Flow cytometric analysis of CD3DX5+ NK cells in splenocytes from wild type, Stat5a−/−, and Stat5b−/− mice. (C–E) Decreased NK cytolytic activity in Stat5b−/− mice in the presence of no cytokine (C), IL-2 (D), or IL-15 (E). Shown are the mean ± SEM from combining two or three independent experiments, each of which had three mice of each genotype. (F) Defective IL-2Rβ expression in NK cells in Stat5b−/− mice, as compared with levels in wild type or Stat5a−/− mice. A total of 14 Stat5a−/− and 17 Stat5b−/− mice were examined.
Figure 4
Figure 4
(A) Northern blotting for perforin or control pHe7 using RNA from fresh splenocytes or from splenocytes treated with IL-2 or IL-15 for 90 h. (B) For each condition, the relative level of perforin mRNA expression in A was normalized for pHe7 expression.

Similar articles

Cited by

References

    1. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331–334. - PubMed
    1. Horvath CM, Darnell JE., Jr The state of STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol. 1997;9:233–239. - PubMed
    1. Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293–322. - PubMed
    1. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996;84:443–450. - PubMed
    1. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84:431–442. - PubMed

Publication types